Statistics

Total Visits

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group84

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: analysis by age group21

Views

Views
December 20251
January 20263
February 20260
March 20265
April 202610
May 20261
June 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
China3
Argentina2
Congo1
Chile1
Colombia1
Spain1
Turkey1
Venezuela1
South Africa1
 

Top cities views

Views
Ashburn3
Antalya1
Benicarló1
Bogotá1
Brazzaville1
Cape Town1
Chicago1
Ciudad Bolívar1
Los Angeles1
San Jose1